Canada markets closed

Vivos Therapeutics, Inc. (VVOS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.6300+0.0300 (+1.15%)
At close: 04:00PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-13,583
-13,583
-23,845
-20,288
-12,057
Depreciation & amortization
621
621
669
733
718
Stock based compensation
1,106
1,106
2,396
2,658
2,172
Change in working capital
2,864
2,864
1,711
28
-431
Accounts receivable
255
255
746
228
-560
Accounts Payable
734
734
491
139
-274
Other working capital
-12,749
-12,749
-20,511
-18,131
-5,800
Other non-cash items
87
87
-
-9
3,918
Net cash provided by operating activites
-11,946
-11,946
-19,587
-15,735
-5,680
Cash flows from investing activities
Investments in property, plant and equipment
-803
-803
-924
-2,396
-120
Acquisitions, net
-
-
0
-225
0
Other investing activites
-50
-50
-
13
-
Net cash used for investing activites
-853
-853
-924
-2,608
-120
Cash flows from financing activities
Debt repayment
-
-
0
-25
-75
Common stock issued
12,000
12,000
0
27,930
22,290
Common stock repurchased
-
-
0
-1,500
-2,150
Other financing activites
-1,077
-1,077
-
-2,238
-245
Net cash used privided by (used for) financing activities
10,923
10,923
0
24,167
23,537
Net change in cash
-1,876
-1,876
-20,511
5,824
17,737
Cash at beginning of period
3,519
3,519
24,030
18,206
469
Cash at end of period
1,643
1,643
3,519
24,030
18,206
Free Cash Flow
Operating Cash Flow
-11,946
-11,946
-19,587
-15,735
-5,680
Capital Expenditure
-803
-803
-924
-2,396
-120
Free Cash Flow
-12,749
-12,749
-20,511
-18,131
-5,800